Log in

Adherium Limited (ADR.AX) Stock Forecast, Price & News

Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume38,277 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Adherium Limited develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, North America, and Asia. It offers Hailie, an asthma and COPD medication adherence solution for patients with chronic respiratory diseases. The company also provides a range of smart device sensors for respiratory medications, such as Bluetooth enabled Hailie sensors wrap around a patient's existing inhalers and automatically send usage data to their smartphone; and Hailie app that enables patients, caregivers, and healthcare professionals to track medication adherence, set daily reminders, and discover insights into their medication usage. It offers its digital health solutions to patients, pharmaceutical companies, healthcare providers, and contract research organizations. The company has a collaboration with HGE Health in COPD. The company was founded in 2001 and is headquartered in Auckland, New Zealand.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 3.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.60 out of 5 stars

Industry, Sector and Symbol

Industry Medical Devices
Phone64 9 307 2771



Sales & Book Value

Annual Sales$2.22 million
Book ValueA$0.01 per share



Next Earnings DateN/A
OptionableNot Optionable

Receive ADR News and Ratings via Email

Sign-up to receive the latest news and ratings for ADR and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Adherium Limited (ADR.AX) (ASX:ADR) Frequently Asked Questions

What stocks does MarketBeat like better than Adherium Limited (ADR.AX)?

Wall Street analysts have given Adherium Limited (ADR.AX) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Adherium Limited (ADR.AX) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of Adherium Limited (ADR.AX)'s key competitors?

Who are Adherium Limited (ADR.AX)'s key executives?

Adherium Limited (ADR.AX)'s management team includes the following people:
  • Mr. Mike Motion, CEO & Exec. Director
  • Ms. Anne M. Bell, Chief Financial Officer
  • Mr. Rob Turnbull B.Com., C.A., B.Com, CA., GM & Joint Company Sec. (Age 53, Pay $293.14k)
  • Mr. Mark Andrew Licciardo B Bus (Acc), FCIS, GAICD, GradDip CSP, FGIA, Joint Company Sec. (Age 56, Pay $7.08k)
  • Mr. Geoff Feakes, Chief Technology Officer
  • Mr. Chris Mander, Head of Regulatory & Quality
  • Ms. Maggie Scott, Head of Clinical Operations
  • Ms. Jane Lapon, Head of Global Market Access & Reimbursement
  • Dr. John Douglas Wilson, Exec. Medical Director (Age 83)

What is Adherium Limited (ADR.AX)'s stock symbol?

Adherium Limited (ADR.AX) trades on the ASX under the ticker symbol "ADR."

How big of a company is Adherium Limited (ADR.AX)?

Adherium Limited (ADR.AX) has a market capitalization of $0.00 and generates $2.22 million in revenue each year.

What is Adherium Limited (ADR.AX)'s official website?

The official website for Adherium Limited (ADR.AX) is www.adherium.com.

How can I contact Adherium Limited (ADR.AX)?

The company can be reached via phone at 64 9 307 2771.

This page was last updated on 11/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.